RecruitingNCT07413900

Biomarkers Study in Infants With Prior Neonatal Brain Injury

Early Biomarkers Study for Prediction of Executive Dysfunction and Cognitive Outcomes Among Infants With Prior Neonatal Brain Injury

Sponsor

University of Wisconsin, Madison

Enrollment

100 participants

Start Date

Mar 13, 2023

Study Type

OBSERVATIONAL

Conditions

Healthy Participants Premature Birth HIE - Hypoxic - Ischemic Encephalopathy Perinatal Anoxic-ischemic Brain Injury

Summary

This research focuses on the long-term cognitive development of children, including healthy infants and those who had a perinatal brain injury. As part of this research study, children complete in-person games and assessments at UW-Madison University Hospital. Children will also take part in an EEG assessment. Parents will be asked to fill out questionnaires about their child's behavior and stress in the home.

Eligibility

Min Age: 3 MonthsMax Age: 24 Months

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with hie - hypoxic - ischemic encephalopathy, healthy participants, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 3 Months to 24 Months.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.